Progyny, Inc. — Director's Dealing 2020

Dec 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Progyny, Inc. (PGNY)
CIK: 0001551306
Period of Report: 2020-12-02

Reporting Person: Payson Norman (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-02	Common Stock	S	2000	$35.89	Disposed	559500	Indirect
2020-12-02	Common Stock	S	3500	$36.49	Disposed	556000	Indirect
2020-12-03	Common Stock	S	5500	$37.08	Disposed	550500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	528446	Direct
Common Stock	122493	Indirect

Footnotes

F1: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.22 to $36.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (7).

F3: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust").

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.24 to $36.98 inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.82 to $37.67 inclusive.

F6: The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.